Development of a universal assay for minimal residual disease in acute myeloid leukemia using duplex sequencing
Ended Grant Awarded Last action
- Award ID
- R44CA233381
- Recipient
-
Twinstrand Biosciences Inc. UEI HPY9BJWV8X31
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,005,321
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Seattle, WA 98121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$659,483 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,985,831 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,139,103 | |
| Amendment | $0 | |
| Amendment | $249,982 | |
| Amendment | $30,486 | |
| Amendment | $579,262 | |
| Amendment | $690,175 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $690,175 | |
| Original award | $299,790 |
Show all 18
Quick answers
Who received award R44CA233381?
R44CA233381 was awarded to Twinstrand Biosciences Inc. by National Cancer Institute (National Institutes of Health) on July 16, 2018.
How much is award R44CA233381 worth?
$5,005,321 has been obligated on R44CA233381.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award